986066959	986066959	CD	B-NP	O
|	|	NN	I-NP	O
SBHMH	SBHMH	NN	I-NP	O
|	|	NN	I-NP	O
15770082	15770082	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
1012327	1012327	CD	B-NP	O
|	|	CC	I-NP	O
4/4/2006	4/4/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
R	R	NN	I-NP	I-protein
femur	femur	NN	I-NP	I-protein
neck	neck	NN	I-NP	I-protein
fracture	fracture	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/19/2006	9/19/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/30/2006	8/30/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
DARROUGH	DARROUGH	NN	B-NP	O
,	,	,	O	O
CURT	CURT	NN	B-NP	O
434-76-10-7	434-76-10-7	CD	I-NP	O
Paul	Paul	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
ORT	ORT	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
10/13/06	10/13/06	CD	B-NP	O
AT	AT	NN	I-NP	O
05	05	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
ROARY	ROARY	NN	B-NP	O
,	,	,	O	O
LAWERENCE	LAWERENCE	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
TYLENOL	TYLENOL	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ACETAMINOPHEN	ACETAMINOPHEN	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
650	650	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
Q4H	Q4H	NNP	I-NP	I-protein
Starting	Starting	NNP	I-NP	I-protein
Today	Today	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
1/30	1/30	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
take	take	VB	B-VP	O
for	for	IN	B-PP	O
2	2	CD	B-NP	O
days	day	NNS	I-NP	O
and	and	CC	O	O
then	then	RB	B-ADVP	O
only	only	RB	B-ADVP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
;	;	:	O	O
do	do	VBP	B-VP	O
not	not	RB	I-VP	O
take	take	VB	I-VP	O
any	any	DT	B-NP	O
additional	additional	JJ	I-NP	O
tylenol	tylenol	NN	I-NP	O
or	or	CC	I-NP	O
vicodin	vicodin	NN	I-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
contains	contain	VBZ	B-VP	O
tylenol	tylenol	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
1/25/06	1/25/06	CD	B-NP	O
by	by	IN	B-PP	O
NOFFSINGER	NOFFSINGER	NN	B-NP	O
,	,	,	O	O
FREDDIE	FREDDIE	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ACETAMINOPHEN	ACETAMINOPHEN	NNP	B-NP	O
&	&	CC	I-NP	O
ACETAMINOPHEN	ACETAMINOPHEN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
ENTERIC	ENTERIC	NNP	B-NP	O
COATED	COATED	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
ATENOLOL	ATENOLOL	NNP	I-NP	O
25	25	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
DULCOLAX	DULCOLAX	NNP	I-NP	O
RECTAL	RECTAL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
BISACODYL	BISACODYL	NNP	I-NP	O
RECTAL	RECTAL	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PR	PR	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Constipation	Constipation	NNP	I-NP	O
COLACE	COLACE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DOCUSATE	DOCUSATE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
NEXIUM	NEXIUM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ESOMEPRAZOLE	ESOMEPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
LASIX	LASIX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
NOVOLOG	NOVOLOG	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
ASPART	ASPART	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
7	7	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
AC	AC	NNP	I-NP	O
HOLD	HOLD	NNP	I-NP	O
IF	IF	NNP	I-NP	O
:	:	:	O	O
npo	npo	NN	B-NP	B-protein
,	,	,	O	O
fs	f	NNS	B-NP	O
<	<	SYM	O	O
60	60	CD	B-NP	O
NOVOLOG	NOVOLOG	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
ASPART	ASPART	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Sliding	Sliding	NNP	I-NP	O
Scale	Scale	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
subcutaneously	subcutaneously	RB	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
SC	SC	NN	I-NP	B-protein
AC	AC	NN	I-NP	I-protein
If	If	IN	B-SBAR	I-protein
BS	BS	NNP	B-NP	I-protein
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
125	125	CD	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
0	0	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
125-150	125-150	CD	B-NP	O
,	,	,	O	O
then	then	RB	O	O
give	give	VB	B-VP	O
2	2	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
151-200	151-200	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
3	3	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
201-250	201-250	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
251-300	251-300	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
6	6	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
301-350	301-350	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
8	8	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
351-400	351-400	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
10	10	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
and	and	CC	O	O
call	call	VB	B-VP	O
HO	HO	NN	B-NP	B-protein
Call	Call	NN	I-NP	I-protein
HO	HO	NN	I-NP	I-protein
if	if	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
400	400	CD	B-NP	B-DNA
INSULIN	INSULIN	NNP	I-NP	I-DNA
NPH	NPH	NNP	I-NP	I-DNA
HUMAN	HUMAN	NNP	I-NP	I-DNA
43	43	CD	I-NP	I-DNA
UNITS	UNITS	NNP	I-NP	I-DNA
QAM	QAM	NNP	I-NP	I-DNA
;	;	:	O	I-DNA
12	12	CD	B-NP	I-DNA
UNITS	UNITS	NNP	I-NP	I-DNA
QPM	QPM	NNP	I-NP	I-DNA
SC	SC	NNP	I-NP	I-DNA
43	43	CD	I-NP	I-DNA
UNITS	UNITS	NNP	I-NP	I-DNA
QAM	QAM	NNP	I-NP	I-DNA
12	12	CD	I-NP	I-DNA
UNITS	UNITS	NNP	I-NP	I-DNA
QPM	QPM	NNP	I-NP	I-DNA
Instructions	Instruction	NNPS	I-NP	I-DNA
:	:	:	O	O
do	do	VB	B-VP	O
not	not	RB	I-VP	O
give	give	VB	I-VP	O
half	half	JJ	B-NP	O
dose	dose	NN	I-NP	O
for	for	IN	B-PP	O
npo	npo	NN	B-NP	B-protein
LACTULOSE	LACTULOSE	NN	I-NP	I-protein
30	30	CD	I-NP	I-protein
MILLILITERS	MILLILITERS	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
Q6H	Q6H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Constipation	Constipation	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
titrate	titrate	VB	B-VP	O
to	to	TO	B-PP	O
BMs	BM	NNS	B-NP	O
LISINOPRIL	LISINOPRIL	NN	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/28/06	10/28/06	CD	B-NP	O
by	by	IN	B-PP	O
KILZER	KILZER	NNP	B-NP	O
,	,	,	O	O
KENTON	KENTON	NNP	B-NP	O
S	S	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
REGLAN	REGLAN	NN	B-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
METOCLOPRAMIDE	METOCLOPRAMIDE	NN	I-NP	O
HCL	HCL	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QID	QID	NNP	I-NP	O
HOLD	HOLD	NNP	I-NP	O
IF	IF	NNP	I-NP	O
:	:	:	O	O
diarrhea	diarrhea	NN	B-NP	B-DNA
PHENERGAN	PHENERGAN	NN	I-NP	I-DNA
-LRB-	-LRB-	NN	I-NP	I-DNA
PROMETHAZINE	PROMETHAZINE	NN	I-NP	I-DNA
HCL	HCL	NN	I-NP	I-DNA
-RRB-	-RRB-	NN	I-NP	I-DNA
25	25	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
QID	QID	NNP	I-NP	I-DNA
PRN	PRN	NNP	I-NP	I-DNA
Nausea	Nausea	NNP	I-NP	I-DNA
ZOCOR	ZOCOR	NNP	I-NP	I-DNA
-LRB-	-LRB-	NNP	I-NP	I-DNA
SIMVASTATIN	SIMVASTATIN	NNP	I-NP	I-DNA
-RRB-	-RRB-	NNP	I-NP	I-DNA
80	80	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
BEDTIME	BEDTIME	NNP	I-NP	I-DNA
Food/Drug	Food/Drug	NNP	I-NP	I-DNA
Interaction	Interaction	NNP	I-NP	I-DNA
Instruction	Instruction	NNP	I-NP	I-DNA
Avoid	Avoid	NNP	I-NP	I-DNA
grapefruit	grapefruit	NN	I-NP	I-DNA
unless	unless	IN	B-SBAR	I-DNA
MD	MD	NN	B-NP	I-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Override	Override	NNP	B-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
1/25/06	1/25/06	CD	B-NP	O
by	by	IN	B-PP	O
BRASE	BRASE	NN	B-NP	B-protein
,	,	,	O	O
RAFAEL	RAFAEL	NN	B-NP	B-protein
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
MULTIVITAMIN	MULTIVITAMIN	NN	B-NP	O
THERAPEUTIC	THERAPEUTIC	NN	I-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
477013650	477013650	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
NIACIN	NIACIN	NNP	I-NP	O
,	,	,	O	O
VIT	VIT	NNP	B-NP	O
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
MULTIVITAMIN	MULTIVITAMIN	NN	B-NP	B-protein
THERAPEUTIC	THERAPEUTIC	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
THERAPEUTIC	THERAPEUTIC	NN	I-NP	I-protein
MULTIVI	MULTIVI	NN	I-NP	I-protein
...	...	:	O	I-protein
-RRB-	-RRB-	SYM	B-NP	I-protein
1	1	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
1/25/06	1/25/06	CD	B-NP	O
by	by	IN	B-PP	O
DELARIVA	DELARIVA	NNP	B-NP	O
,	,	,	O	O
JESSIE	JESSIE	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
NIACIN	NIACIN	NNP	I-NP	O
,	,	,	O	O
VIT	VIT	NNP	B-NP	O
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
ULTRAM	ULTRAM	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
TRAMADOL	TRAMADOL	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
50	50	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
q4-6	q4-6	NN	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
1/30	1/30	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
HOLD	HOLD	NNP	I-NP	O
IF	IF	NNP	I-NP	O
:	:	:	O	O
RR	RR	NN	B-NP	B-protein
<	<	SYM	O	I-protein
9	9	CD	B-NP	I-protein
,	,	,	O	O
sedation	sedation	NN	B-NP	O
,	,	,	O	O
O2	O2	NN	B-NP	O
sat	sit	VBD	B-VP	O
<	<	SYM	B-NP	O
93	93	CD	B-NP	O
%	%	NN	I-NP	O
CALTRATE	CALTRATE	NN	I-NP	O
600	600	CD	I-NP	O
+	+	SYM	I-NP	O
D	D	NN	I-NP	O
-LRB-	-LRB-	SYM	O	O
CALCIUM	CALCIUM	NN	B-NP	O
CARBONATE	CARBONATE	NN	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
500	500	CD	I-NP	O
MG	MG	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
...	...	:	O	O
-RRB-	-RRB-	SYM	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
2100	2100	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
weight	weight	NN	B-NP	O
bearing	bear	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Woolverton	Woolverton	NNP	I-NP	O
,	,	,	O	O
call	call	VBP	B-VP	O
689-346-8223	689-346-8223	CD	B-NP	O
for	for	IN	B-PP	O
appointment	appointment	NN	B-NP	B-protein
2-3	2-3	CD	B-NP	I-protein
weeks	week	NNS	I-NP	I-protein
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
NKA	NKA	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
R	R	NN	B-NP	O
femur	femur	NN	I-NP	O
neck	neck	NN	I-NP	O
fracture	fracture	NN	I-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
R	R	NNP	I-NP	O
femur	femur	NN	I-NP	O
neck	neck	NN	I-NP	O
fracture	fracture	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
CAD	CAD	NN	I-NP	O
HTN	HTN	NN	I-NP	O
high	high	JJ	I-NP	O
cholesterol	cholesterol	NN	I-NP	O
IDDM	IDDM	NN	I-NP	O
s/p	s/p	NN	I-NP	O
BKA	BKA	NN	I-NP	O
L	L	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NNP	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
physical	physical	JJ	I-NP	O
therapy	therapy	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
Mr.	Mr.	NNP	B-NP	O
Codde	Codde	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
56	56	CD	I-NP	O
yo	yo	NN	I-NP	O
malel	malel	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
h/o	h/o	NN	I-NP	O
IDDM	IDDM	NN	I-NP	O
,	,	,	O	O
peripheral	peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
CAD	CAD	NN	B-NP	B-protein
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
BKA	BKA	NN	I-NP	O
on	on	IN	B-PP	O
L	L	NN	B-NP	O
who	who	WP	B-NP	O
tripped	trip	VBD	B-VP	O
over	over	IN	B-PP	O
rolled	roll	VBN	B-NP	O
carpet	carpet	NN	I-NP	O
at	at	IN	B-PP	O
home/garage	home/garage	NN	B-NP	O
,	,	,	O	O
fell	fall	VBD	B-VP	O
and	and	CC	I-VP	O
broke	break	VBD	I-VP	O
R	R	NN	B-NP	O
femur/neck	femur/neck	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
here	here	RB	B-ADVP	O
from	from	IN	B-PP	O
an	an	DT	B-NP	O
outside	outside	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
on	on	IN	B-PP	O
5/4/06	5/4/06	CD	B-NP	O
.	.	.	O	O

Medicine	Medicine	NN	B-NP	O
,	,	,	O	O
cardiology	cardiology	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
endocrinology	endocrinology	NN	B-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
for	for	IN	B-PP	O
preoperative	preoperative	JJ	B-NP	O
optimization	optimization	NN	I-NP	O
of	of	IN	B-PP	O
care	care	NN	B-NP	O
and	and	CC	I-NP	O
risk	risk	NN	I-NP	O
stratification	stratification	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
the	the	DT	B-NP	O
OR	OR	NN	I-NP	B-protein
on	on	IN	B-PP	O
1/8/06	1/8/06	CD	B-NP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Summerhill	Summerhill	NNP	I-NP	O
for	for	IN	B-PP	O
R	R	NN	B-NP	O
hip	hip	NN	I-NP	O
pinning	pinning	NN	I-NP	O
.	.	.	O	O

See	See	VB	B-VP	O
full	full	JJ	B-NP	O
operative	operative	JJ	I-NP	O
note	note	NN	I-NP	O
for	for	IN	B-PP	O
details	detail	NNS	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
tolerated	tolerate	VBD	B-VP	O
the	the	DT	B-NP	O
procedure	procedure	NN	I-NP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

Postoperatively	Postoperatively	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
did	do	VBD	B-VP	O
well	well	RB	B-ADVP	O
also	also	RB	B-ADVP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
postoperative	postoperative	JJ	I-NP	O
course	course	NN	I-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
edema	edema	NN	I-NP	O
which	which	WDT	B-NP	O
responded	respond	VBD	B-VP	O
very	very	RB	B-ADVP	O
well	well	RB	I-ADVP	O
to	to	TO	B-PP	O
diuresis	diuresis	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
went	go	VBD	B-VP	O
from	from	IN	B-PP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
face	face	NN	I-NP	O
mask	mask	NN	I-NP	O
on	on	IN	B-PP	O
POD	POD	NN	B-NP	B-protein
1	1	CD	I-NP	I-protein
to	to	TO	B-PP	O
RA	RA	NN	B-NP	O
within	within	IN	B-PP	O
2	2	CD	B-NP	O
days	day	NNS	I-NP	O
with	with	IN	B-PP	O
monitored	monitor	VBN	B-NP	O
diuresis	diuresis	NN	I-NP	O
and	and	CC	I-NP	O
electrolyte	electrolyte	NN	I-NP	O
replacement	replacement	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
and	and	CC	O	O
remained	remain	VBD	B-VP	O
hemodynamically	hemodynamically	RB	B-ADJP	O
stable	stable	JJ	I-ADJP	O
.	.	.	O	O

Endocrinology	Endocrinology	NNP	B-NP	O
followed	follow	VBD	B-VP	O
him	him	PRP	B-NP	O
and	and	CC	O	O
made	make	VBD	B-VP	O
recommendations	recommendation	NNS	B-NP	O
daily	daily	RB	B-ADVP	O
for	for	IN	B-PP	O
adjustment	adjustment	NN	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
insulin	insulin	NN	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
also	also	RB	B-ADVP	O
recommended	recommend	VBD	B-VP	O
continuing	continue	VBG	I-VP	O
his	his	PRP$	B-NP	O
caltrate	caltrate	NN	I-NP	O
+	+	SYM	O	O
vitamin	vitamin	NN	B-NP	O
D	D	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
some	some	DT	B-NP	O
emesis	emesis	NN	I-NP	O
postop	postop	NN	I-NP	O
which	which	WDT	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
respond	respond	VB	I-VP	O
to	to	TO	B-PP	O
zofran	zofran	NN	B-NP	O
but	but	CC	O	O
did	do	VBD	B-VP	O
to	to	TO	I-VP	O
phenergan	phenergan	VB	I-VP	O
.	.	.	O	O

Today	Today	NN	B-NP	O
he	he	PRP	B-NP	O
tolerated	tolerate	VBD	B-VP	O
lunch	lunch	NN	B-NP	O
well	well	RB	B-ADVP	O
and	and	CC	O	O
by	by	IN	B-PP	O
dinner	dinner	NN	B-NP	O
,	,	,	O	O
wife	wife	NN	B-NP	O
and	and	CC	I-NP	O
patient	patient	NN	I-NP	O
feel	feel	VBP	B-VP	O
comfortable	comfortable	JJ	B-ADJP	O
and	and	CC	O	O
in	in	IN	B-PP	O
fact	fact	NN	B-NP	O
prefer	prefer	VBP	B-VP	O
to	to	TO	I-VP	O
go	go	VB	I-VP	O
home	home	NN	B-ADVP	O
today	today	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
afebrile	afebrile	JJ	B-NP	O
,	,	,	I-NP	O
vital	vital	JJ	I-NP	O
signs	sign	NNS	I-NP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-ADJP	O
,	,	,	O	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
RA	RA	NN	B-NP	B-protein
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
RRR	RRR	NN	B-NP	B-protein
,	,	,	O	O
lungs	lung	VBZ	B-VP	O
CTAB	CTAB	NN	B-NP	B-protein
.	.	.	O	O

R	R	NN	B-NP	O
hip	hip	NN	I-NP	O
incision	incision	NN	I-NP	O
clean	clean	NN	I-NP	O
,	,	,	O	O
dry	dry	JJ	B-ADJP	O
,	,	,	O	O
intact	intact	JJ	B-ADJP	O
with	with	IN	B-PP	O
staples	staple	NNS	B-NP	O
.	.	.	O	O

STrenght	STrenght	NN	B-NP	O
5/5	5/5	CD	I-NP	O
RLE	RLE	NN	I-NP	O
and	and	CC	I-NP	O
sensation	sensation	NN	I-NP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
prosthesis	prosthesis	NN	B-NP	O
on	on	IN	B-PP	O
left	left	JJ	B-NP	O
LLE	LLE	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
cleared	clear	VBN	I-VP	O
by	by	IN	B-PP	O
PT	PT	NN	B-NP	O
if	if	IN	B-SBAR	O
ambulance	ambulance	NN	B-NP	O
takes	take	VBZ	B-VP	O
him	him	PRP	B-NP	O
home	home	NN	B-ADVP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
24hrs	24hr	NNS	B-NP	O
supervision	supervision	NN	I-NP	O
which	which	WDT	B-NP	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
abulatory	abulatory	JJ	B-ADJP	O
with	with	IN	B-PP	O
walker	walker	NN	B-NP	O
and	and	CC	I-NP	O
cane	cane	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
special	special	JJ	B-NP	O
commode	commode	NN	I-NP	O
ordered	order	VBN	B-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
return	return	VB	I-VP	O
to	to	TO	I-VP	O
see	see	VB	I-VP	O
Dr.	Dr.	NNP	B-NP	O
Perine	Perine	NNP	I-NP	O
in	in	IN	B-PP	O
clinic	clinic	NN	B-NP	O
in	in	IN	B-PP	O
2	2	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
being	be	VBG	I-VP	O
discharged	discharge	VBN	I-VP	O
home	home	NN	B-ADVP	O
with	with	IN	B-PP	O
reglan	reglan	NN	B-NP	O
and	and	CC	I-NP	O
phenergan	phenergan	NN	I-NP	O
for	for	IN	B-PP	O
nausea	nausea	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
have	have	VB	I-VP	O
VNA	VNA	NN	B-NP	B-protein
and	and	CC	I-NP	O
home	home	NN	I-NP	O
PT	PT	NN	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
keep	keep	NN	I-NP	O
incision	incision	NN	I-NP	O
clean	clean	JJ	I-NP	O
and	and	CC	I-NP	O
dry	dry	JJ	I-NP	B-protein
2	2	CD	I-NP	I-protein
-RRB-	-RRB-	HYPH	O	O
you	you	PRP	B-NP	O
are	be	VBP	B-VP	O
weight	weight	JJ	B-NP	O
bearing	bearing	NN	I-NP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-VP	O
but	but	CC	O	O
use	use	VBP	B-VP	O
walker	walker	NN	B-NP	O
for	for	IN	B-PP	O
now	now	RB	B-NP	O
and	and	CC	O	O
have	have	VBP	B-VP	O
24hrs	24hr	VBN	I-VP	O
supervision	supervision	NN	B-NP	O
at	at	IN	B-PP	O
all	all	DT	B-NP	O
times	time	NNS	I-NP	O
3	3	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
call	call	NN	I-NP	O
for	for	IN	B-PP	O
redness	redness	NN	B-NP	O
,	,	,	O	O
fever	fever	NN	B-NP	O
>	>	SYM	B-VP	O
101	101	CD	B-NP	O
,	,	,	O	O
drainage	drainage	NN	B-NP	O
from	from	IN	B-PP	O
incision	incision	NN	B-NP	O
or	or	CC	B-PP	O
if	if	IN	B-SBAR	O
vomiting	vomiting	NN	B-NP	O
continues	continue	VBZ	B-VP	O
for	for	IN	B-PP	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
3	3	CD	I-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
stop	stop	VBP	B-VP	O
passing	pass	VBG	I-VP	O
stool	stool	NN	B-NP	O
or	or	CC	I-NP	O
flatus	flatus	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
NEREN	NEREN	NNP	B-NP	O
,	,	,	O	O
KIM	KIM	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
YM32	YM32	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10/13/06	10/13/06	CD	I-NP	O
@	@	SYM	B-NP	O
06	06	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

